Using prostate tissue from the biopsy obtained at the time of diagnosis (no new sampling of the prostate is needed) the gene expression of the sample is analyzed. The information from the genes is then combined with other clinical parameters and the so called P-Score is calculated, which shows the risk of dying from prostate cancer.